Sanofi SA (France) Price Prediction
| SAN Stock | EUR 90.87 0.07 0.08% |
Oversold Vs Overbought
36
Oversold | Overbought |
Using Sanofi SA hype-based prediction, you can estimate the value of Sanofi SA from the perspective of Sanofi SA response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Sanofi SA to buy its stock at a price that has no basis in reality. In that case, they are not buying Sanofi because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Sanofi SA after-hype prediction price | EUR 90.87 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Sanofi |
Sanofi SA After-Hype Price Prediction Density Analysis
As far as predicting the price of Sanofi SA at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Sanofi SA or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Sanofi SA, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Sanofi SA Estimiated After-Hype Price Volatility
In the context of predicting Sanofi SA's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Sanofi SA's historical news coverage. Sanofi SA's after-hype downside and upside margins for the prediction period are 89.79 and 91.95, respectively. We have considered Sanofi SA's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Sanofi SA is very steady at this time. Analysis and calculation of next after-hype price of Sanofi SA is based on 3 months time horizon.
Sanofi SA Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Sanofi SA is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Sanofi SA backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Sanofi SA, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.15 | 1.08 | 0.00 | 0.00 | 0 Events / Month | 0 Events / Month | Within a week |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
90.87 | 90.87 | 0.00 |
|
Sanofi SA Hype Timeline
Sanofi SA is at this time traded for 90.87on Euronext Paris of France. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Sanofi is estimated not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is estimated to be very small, whereas the daily expected return is at this time at -0.15%. %. The volatility of related hype on Sanofi SA is about 0.0%, with the expected price after the next announcement by competition of 90.87. About 47.0% of the company shares are owned by institutional investors. The company has price-to-book ratio of 1.61. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Sanofi SA has Price/Earnings To Growth (PEG) ratio of 1.63. The entity recorded earning per share (EPS) of 6.66. The firm last dividend was issued on the 6th of May 2022. Sanofi SA had 4:1 split on the 24th of May 1999. Assuming the 90 days trading horizon the next estimated press release will be within a week. Check out Sanofi SA Basic Forecasting Models to cross-verify your projections.Sanofi SA Related Hype Analysis
Having access to credible news sources related to Sanofi SA's direct competition is more important than ever and may enhance your ability to predict Sanofi SA's future price movements. Getting to know how Sanofi SA's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Sanofi SA may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| AI | Air Liquide SA | 0.00 | 0 per month | 0.00 | (0.14) | 1.67 | (2.04) | 4.88 | |
| CS | AXA SA | 0.00 | 0 per month | 1.03 | (0.09) | 1.22 | (1.51) | 4.27 | |
| BN | Danone SA | 0.00 | 0 per month | 0.55 | (0.02) | 1.24 | (1.04) | 4.49 | |
| DG | Vinci SA | 0.00 | 0 per month | 0.00 | (0.13) | 2.04 | (1.77) | 7.20 | |
| OR | LOreal SA | 0.00 | 0 per month | 0.00 | (0.22) | 2.44 | (2.60) | 10.83 |
Sanofi SA Additional Predictive Modules
Most predictive techniques to examine Sanofi price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Sanofi using various technical indicators. When you analyze Sanofi charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Sanofi SA Predictive Indicators
The successful prediction of Sanofi SA stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Sanofi SA, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Sanofi SA based on analysis of Sanofi SA hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Sanofi SA's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Sanofi SA's related companies.
Story Coverage note for Sanofi SA
The number of cover stories for Sanofi SA depends on current market conditions and Sanofi SA's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Sanofi SA is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Sanofi SA's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Other Macroaxis Stories
Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios
Story Categories
Currently Trending Categories
Sanofi SA Short Properties
Sanofi SA's future price predictability will typically decrease when Sanofi SA's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Sanofi SA often depends not only on the future outlook of the potential Sanofi SA's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Sanofi SA's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 1.3 B | |
| Cash And Short Term Investments | 12.7 B |
Complementary Tools for Sanofi Stock analysis
When running Sanofi SA's price analysis, check to measure Sanofi SA's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sanofi SA is operating at the current time. Most of Sanofi SA's value examination focuses on studying past and present price action to predict the probability of Sanofi SA's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sanofi SA's price. Additionally, you may evaluate how the addition of Sanofi SA to your portfolios can decrease your overall portfolio volatility.
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like |